Suppr超能文献

滤泡性淋巴瘤中基于芯片的DNA甲基化分析

Array-based DNA methylation profiling in follicular lymphoma.

作者信息

O'Riain C, O'Shea D M, Yang Y, Le Dieu R, Gribben J G, Summers K, Yeboah-Afari J, Bhaw-Rosun L, Fleischmann C, Mein C A, Crook T, Smith P, Kelly G, Rosenwald A, Ott G, Campo E, Rimsza L M, Smeland E B, Chan W C, Johnson N, Gascoyne R D, Reimer S, Braziel R M, Wright G W, Staudt L M, Lister T A, Fitzgibbon J

机构信息

Centre for Medical Oncology, Barts and the London School of Medicine and Dentistry, Institute of Cancer, London EC1M 6BQ, UK.

出版信息

Leukemia. 2009 Oct;23(10):1858-66. doi: 10.1038/leu.2009.114. Epub 2009 Jul 9.

Abstract

Quantitative methylation profiling was performed using the Illumina GoldenGate Assay in untreated follicular lymphoma (FL) (164), paired pre- and post-transformation FL (20), benign haematopoietic (24) samples and purified B and T cells from two FL cases. Methylation values allowed separation of untreated FL samples from controls with one exception, based primarily on tumour-specific gains of methylation typically occurring within CpG islands. Genes that are targets for epigenetic repression in stem cells by Polycomb Repressor Complex 2 were significantly over-represented among hypermethylated genes. Methylation profiles were conserved in sequential FL and t-FL biopsies, suggesting that widespread methylation represents an early event in lymphomagenesis and may not contribute substantially to transformation. A significant (P<0.05) correlation between FL methylation values and reduced gene expression was shown for up to 28% of loci. Methylation changes occurred predominantly in B cells with variability in the amount of non-malignant tissue between samples preventing conclusive correlation with survival. This represents an important caveat in attributing prognostic relevance to methylation and future studies in cancer will optimally require purified tumour populations to address the impact of methylation on clinical outcome.

摘要

使用Illumina GoldenGate检测法对未经治疗的滤泡性淋巴瘤(FL)(164例)、转化前后配对的FL(20例)、良性造血样本(24例)以及来自2例FL病例的纯化B细胞和T细胞进行了定量甲基化分析。甲基化值能够将未经治疗的FL样本与对照区分开来,但有一个例外,这主要基于通常发生在CpG岛中的肿瘤特异性甲基化增加。在干细胞中被多梳抑制复合物2表观遗传抑制的基因在高甲基化基因中显著富集。甲基化谱在连续的FL和t-FL活检中是保守的,这表明广泛的甲基化是淋巴瘤发生的早期事件,可能对转化没有实质性贡献。高达28%的位点显示FL甲基化值与基因表达降低之间存在显著(P<0.05)相关性。甲基化变化主要发生在B细胞中,样本间非恶性组织数量的差异阻碍了与生存的确切相关性。这是将甲基化的预后相关性归因时的一个重要注意事项,未来的癌症研究将最理想地需要纯化的肿瘤群体来解决甲基化对临床结果的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/751b/2762475/3275ef09ec18/ukmss-4607-f0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验